文献速递肾移植血液净化与透析

肾移植与透析患者对RSVPreF3OA疫苗的免疫应答对比健康对照

RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls.
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

该观察性队列分析23例肾移植受者、14例透析患者和24例健康对照接种RSVPreF3OA疫苗后30天和90天的体液与细胞免疫应答。肾移植受者应答特征与健康对照相似,而透析患者应答延迟且减弱。

要点

  • 肾移植受者接种RSVPreF3OA后抗体和RSV特异性B/T细胞应答与健康对照相似。
  • 透析患者接种后体液和细胞应答延迟且减弱。
  • 各队列RSV特异性B/T细胞表型和功能特征可比。

核心结论

  • RSVPreF3OA疫苗在肾移植受者中诱导与健康对照相当的保护性RSV应答,透析患者应答适度降低。

研究设计与样本

  • 观察性队列分析23例肾移植受者、14例透析患者和24例健康对照,接种佐剂预融合F蛋白RSVPreF3OA疫苗,基线和接种后30天、90天采集血和唾液。

主要发现

  • 肾移植受者接种后血清和唾液抗体升高,RSV特异性B细胞扩增且富集独特转换记忆表型,诱导RSV-A和RSV-B特异性T细胞及效应细胞因子产生。
  • 肾移植受者应答特征与健康对照相似,而透析患者应答延迟且减弱。
  • 各队列RSV特异性B和T细胞表型与功能特征可比。

临床怎么用

  • 肾移植受者可考虑接种RSVPreF3OA疫苗以获得与健康对照相似的免疫应答。
  • 透析患者接种后免疫应答较弱,需关注其保护效果可能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Respiratory syncytial virus (RSV) causes severe respiratory illness in vulnerable populations, including kidney transplant recipients (KTRs) and dialysis patients (DPs). Despite the availability of RSV prefusion F protein-based vaccines, immune phenotyping of vaccine-specific B and T cells in KTRs and DPs remains limited. We hypothesized that RSVPreF3OA vaccination induces distinct immune signatures in KTRs and DPs compared with healthy controls (HCs), reflecting the impact of immunosuppression and uraemia on vaccine-induced B and T cell responses. METHODS: In this observational cohort, we analysed humoral and cellular responses following routine vaccination with the adjuvanted prefusion F protein-based RSVPreF3OA vaccine in 23 KTRs, 14 DPs and 24 HCs. Blood and saliva were collected at baseline and on days 30 and 90 post-vaccination. RSV-specific serum immunoglobulin G/immunoglobulin A, salivary antibodies and antigen-specific B and T cells were quantified by enzyme-linked immunosorbent assay and spectral flow cytometry, with tetanus- and severe acute respiratory syndrome coronavirus 2-specific responses assessed in parallel. RESULTS: In KTRs, vaccination induced increases in serum and salivary antibodies, expansion of RSV-specific B cells with enrichment of a switched memory phenotype unique to RSV-specific B cells and induction of RSV-A- and RSV-B-specific T cells with effector cytokine production. These signatures resembled those observed in HCs, whereas responses in DPs were delayed and attenuated. Across cohorts, RSV-specific B and T cells showed comparable phenotypic and functional characteristics. CONCLUSIONS: This study provides detailed immunophenotyping of RSVPreF3OA vaccine responses in KTRs, DPs and HCs over 90 days, showing that RSVPreF3OA vaccination induces protective RSV responses among KTRs comparable to HCs while DPs mount modestly lower cellular and humoral responses.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Rincon-Arevalo H, Halleck F, Böger D, et al. RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls. Nephrol Dial Transplant. 2026. PMID: 41528367. doi:10.1093/ndt/gfag002

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。